Mechanical Dialogues of Life and Death: How External Molecules Entry Triggers a Chromatin-Cytoskeleton Morphogenetic

Parama Dey1,2, Anup Singhania1,3,4, Ajaikumar B Kunnumakkara1

  • 1Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati, Assam, India.

Advanced Biology
|February 20, 2026
PubMed

Insights

Next-generation cancer therapy uses PCMS (PAMAM-based supramolecule) to mechanically disrupt cancer cells. This novel mechanotherapeutic reprograms cellular mechanics, leading to cancer cell death by exploiting internal adaptive feedback loops.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Cellular Mechanics

Background:

  • Next-generation anti-cancer therapeutics require novel mechanisms beyond simple toxicity.
  • Disrupting intracellular mechanics offers a new strategy for cancer cell eradication.
  • PAMAM-based supramolecules (PCMS) are emerging as potential agents for targeted cellular manipulation.

Purpose of the Study:

  • To evaluate the mechanism of action of PCMS, a PAMAM-based supramolecule, in eradicating cancer cells.
  • To investigate how PCMS reorganizes intracellular mechanics to induce cancer cell death.
  • To establish PCMS as a novel class of mechanotherapeutics targeting cellular adaptive feedback.

Main Methods:

  • Internalization and self-assembly of PCMS within cancer cells.
  • Observation of PCMS-induced perinuclear ring formation and nucleus-cytoskeleton communication disruption.
  • Analysis of cytoskeletal rescue and nuclear counter-expansion phenomena using advanced microscopy and biophysical techniques.

Main Results:

  • PCMS self-assembles into a perinuclear ring, severing nucleus-cytoskeleton communication.
  • Observed dual mechanisms: cytoskeletal rescue and nuclear counter-expansion, leading to amplified mechanical stress.
  • PCMS induces nuclear lysis via geometric collapse of the actin-microtubule-nucleus continuum without significant transcriptional changes.

Conclusions:

  • PCMS eradicates cancer cells by mechanically disrupting intracellular processes, not by genetic modification.
  • The study establishes a paradigm of 'mechanical deception' for cancer therapy.
  • PCMS represents a new class of mechanotherapeutics that exploit cellular morphogenetic logic to overcome resistance.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cell-matrix's Response to Mechanical Forces01:13

Cell-matrix's Response to Mechanical Forces

In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue. 
Anchoring junctions mechanically attach a cell to the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...